NASDAQ·US·Drug Manufacturers - Specialty & Generic
VTRSVTRS
0คะแนน
สรุป
ควรหลีกเลี่ยง
ความมั่นใจ 85%
$14.97—
Today's session
Upside?
+40.2%
FV $20.99
P/E (TTM)?
—
Earnings yield
FCF yield?
13.9%
Mcap $17.43B
ซื้อ
Fundamental neutral·Technical buy
What investors notice
Key signs
Plain-language read of the metrics that matter most for this stock.
Net negative
3 · 1 · 6
Strengths
- Long-term debt declining year-over-year
- Trading well below consensus fair value40%
- High FCF yield14%
Risks
- Capital efficiency is weak (low ROE)-4%
- Inconsistent profitability2/10
- EPS shrinking on a 5-year basis-100%
- Highly leveraged (Net Debt > 4× EBITDA)13.6×
- Operating profit barely covers interest0.3×
- ROIC below WACC — destroying value-6%
Watchlist
- Gross margins under pressure
$14.97+87.9%
1Y · period change vs 2025-04-29
Score history (10y)
How quality has trended through cycles.
Verdict bands: 85+ Wonderful · 70 Solid · 55 Average · 40 Risky.
Fair value range
5 of 5 models · trimmed-mean consensus
Consensus FV
$20.99
Upside
+40.2%
Now $14.97
Our FV$20.99
Price$14.97
$2.78$66.41
Open the Fair Value tab to tweak WACC and growth, and to see all five model outputs side-by-side.
10-year financials
Annual revenue, profit, and free cash flow with year-over-year growth overlay.
YoY growth overlaid
Snapshot
At a glance
Top-line figures most investors check first.
Market cap
$17.43B
P/E (TTM)?
—
FCF yield?
13.9%
Dividend
$0.48
3.2% yield
52w range
$7.97 – $15.99
Score confidence
85%
Data completeness
Last updated 4/30/2026, 5:21:55 AM · Data via Yahoo Finance, FMP, EDGAR. Disclaimer